The short answer
The relevant code family distinguishes axillary eccrine-gland treatment (64650) from other areas (64653). Do not use 64640 as a generic underarm-sweating code. Confirm the full current CPT instructions, anatomy, documented service and applicable coverage policy before billing.
Correct the anatomy mapping
The CMS botulinum toxin billing article includes 64650 and 64653 for eccrine-gland chemodenervation. Axillary and non-axillary work are not interchangeable categories. Avoid copying a code from a prior patient or from a generic procedure name in the schedule.
Check indication and payer conditions separately
A procedure code’s existence does not establish that a particular site or indication is FDA approved or covered. BOTOX labeling addresses severe primary axillary hyperhidrosis under stated conditions. Review the actual label and payer policy for the planned service.
Your practical checklist
- Document the precise anatomical area and indication.
- Review the current code’s laterality and reporting instructions.
- Check the patient’s coverage policy and any required prior therapies.
- Keep drug supply and procedure reporting as separate review decisions.
A worked example
Two visits both say “sweating treatment,” but one concerns underarms and another concerns palms. A schedule label is insufficient to reuse the same code. The coding reviewer needs the signed procedure record and payer requirements for each case.
Illustrative workflow example; not a patient case or individualized recommendation.
Mistakes to avoid
- Mapping 64640 to axillary eccrine-gland treatment.
- Describing 64650 as the code for every non-axillary site.
- Assuming off-label treatment must always be covered or never be covered.